Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve
Prenetics Global (NASDAQ: PRE) has announced a strategic partnership with Humanity Protocol to integrate its CircleDNA service for blockchain-based identity verification. The collaboration aims to provide secure Proof of Personhood credentials using DNA testing and zero-knowledge proof technology.
The company has established a Crypto Strategic Reserve with initial investments of $1.5M distributed across $H tokens ($1M), Bitcoin ($250K), and Solana ($250K). These investments will be reviewed quarterly. Prenetics reported $84.87M in cash and short-term assets as of December 31, 2024.
Additionally, through its joint venture Insighta, Prenetics is advancing in decentralized science (DeSci) with AI-driven early cancer detection, supported by a $30M investment from Tencent. The company's consumer health brand, IM8, is also contributing to DeSci initiatives by applying scientific advancements to daily health and longevity solutions.
Prenetics Global (NASDAQ: PRE) ha annunciato una partnership strategica con Humanity Protocol per integrare il servizio CircleDNA per la verifica dell'identità basata su blockchain. La collaborazione mira a fornire credenziali sicure di Proof of Personhood utilizzando test del DNA e tecnologia di prova a conoscenza zero.
L'azienda ha stabilito una Crypto Strategic Reserve con investimenti iniziali di $1.5M distribuiti in token $H ($1M), Bitcoin ($250K) e Solana ($250K). Questi investimenti saranno esaminati trimestralmente. Prenetics ha riportato $84.87M in contante e beni a breve termine al 31 dicembre 2024.
In aggiunta, attraverso la sua joint venture Insighta, Prenetics sta avanzando nella scienza decentralizzata (DeSci) con rilevamento precoce del cancro supportato da un investimento di $30M da Tencent. Il marchio di salute dei consumatori dell'azienda, IM8, contribuisce anche alle iniziative DeSci applicando i progressi scientifici a soluzioni di salute quotidiana e longevità.
Prenetics Global (NASDAQ: PRE) ha anunciado una asociación estratégica con Humanity Protocol para integrar su servicio CircleDNA para la verificación de identidad basada en blockchain. La colaboración tiene como objetivo proporcionar credenciales seguras de Proof of Personhood utilizando pruebas de ADN y tecnología de prueba de conocimiento cero.
La empresa ha establecido una Crypto Strategic Reserve con inversiones iniciales de $1.5M distribuidos en tokens $H ($1M), Bitcoin ($250K) y Solana ($250K). Estas inversiones se revisarán trimestralmente. Prenetics informó de $84.87M en efectivo y activos a corto plazo al 31 de diciembre de 2024.
Además, a través de su empresa conjunta Insighta, Prenetics está avanzando en ciencia descentralizada (DeSci) con detección temprana de cáncer impulsada por IA, respaldada por una inversión de $30M de Tencent. La marca de salud del consumidor de la empresa, IM8, también está contribuyendo a las iniciativas DeSci aplicando avances científicos a las soluciones de salud diaria y longevidad.
프레네틱스 글로벌 (NASDAQ: PRE)는 블록체인 기반의 신원 확인을 위해 CircleDNA 서비스를 통합하는 전략적 파트너십을 Humanity Protocol과 발표했습니다. 이 협력의 목표는 DNA 테스트와 제로 지식 증명 기술을 사용하여 안전한 개인 인증(PoP) 자격 증명을 제공하는 것입니다.
회사는 암호화폐 전략적 준비금을 $1.5M의 초기 투자로 구축했으며, $H 토큰($1M), 비트코인($250K), 솔라나($250K)에 분산되었습니다. 이러한 투자는 분기마다 검토될 것입니다. 프레네틱스는 2024년 12월 31일 기준으로 $84.87M의 현금 및 단기 자산을 보고했습니다.
또한, 프레네틱스는 공동 투자 프로젝트인 Insighta를 통해 AI 기반의 조기 암 탐지로 탈중앙화 과학(DeSci) 분야에서 발전하고 있으며, 텐센트의 $30M 투자를 지원받고 있습니다. 회사의 소비자 건강 브랜드인 IM8도 일상 건강 및 장수 솔루션에 과학적 발전을 적용하여 DeSci 이니셔티브에 기여하고 있습니다.
Prenetics Global (NASDAQ: PRE) a annoncé un partenariat stratégique avec Humanity Protocol pour intégrer son service CircleDNA pour la vérification d'identité basée sur la blockchain. Cette collaboration vise à fournir des certificats de Preuve de Personnalité sécurisés grâce à des tests ADN et à la technologie de preuve à connaissance nulle.
L'entreprise a établi une Réserve Stratégique Crypto avec des investissements initiaux de 1,5 million de dollars répartis en jetons $H (1 million de dollars), Bitcoin (250 000 dollars) et Solana (250 000 dollars). Ces investissements seront examinés trimestriellement. Prenetics a rapporté 84,87 millions de dollars en liquidités et actifs à court terme au 31 décembre 2024.
De plus, à travers sa coentreprise Insighta, Prenetics progresse dans la science décentralisée (DeSci) avec une détection précoce du cancer alimentée par l'IA, soutenue par un investissement de 30 millions de dollars de Tencent. La marque de santé des consommateurs de l'entreprise, IM8, contribue également aux initiatives DeSci en appliquant les avancées scientifiques à des solutions de santé quotidiennes et de longévité.
Prenetics Global (NASDAQ: PRE) hat eine strategische Partnerschaft mit Humanity Protocol angekündigt, um seinen CircleDNA-Service für blockchain-basierte Identitätsüberprüfung zu integrieren. Die Zusammenarbeit zielt darauf ab, sichere Nachweise der Personeneigenschaft mit DNA-Tests und Zero-Knowledge-Proof-Technologie bereitzustellen.
Das Unternehmen hat eine Krypto-Strategische Reserve mit anfänglichen Investitionen von 1,5 Millionen US-Dollar eingerichtet, die sich auf $H-Token (1 Million US-Dollar), Bitcoin (250.000 US-Dollar) und Solana (250.000 US-Dollar) verteilen. Diese Investitionen werden vierteljährlich überprüft. Prenetics meldete zum 31. Dezember 2024 84,87 Millionen US-Dollar in Bar und kurzfristigen Vermögenswerten.
Darüber hinaus bringt Prenetics durch sein Joint Venture Insighta Fortschritte in der dezentralisierten Wissenschaft (DeSci) mit KI-gestützter Früherkennung von Krebs, unterstützt durch eine 30-Millionen-Dollar-Investition von Tencent, voran. Die Verbrauchergesundheitsmarke des Unternehmens, IM8, trägt ebenfalls zu den DeSci-Initiativen bei, indem sie wissenschaftliche Fortschritte auf tägliche Gesundheits- und Langlebigkeitslösungen anwendet.
- Strategic partnership with Humanity Protocol valued at $1.1bn
- Strong balance sheet with $84.87M in cash and short-term assets
- $30M investment from Tencent for AI-driven cancer detection
- Diversification into digital assets through $1.5M crypto investment
- None.
Insights
This multi-faceted announcement represents a strategic transformation for Prenetics, merging genomics with blockchain technology in three key areas: identity verification, digital asset investment and decentralized science (DeSci).
The partnership with Humanity Protocol (valued at
The company's
Most compelling is the
- Decentralized Science (DeSci)
- AI-powered healthcare diagnostics
- Blockchain identity solutions
The regulatory environment for these initiatives remains complex, particularly regarding healthcare data privacy and crypto asset management. However, Prenetics' emphasis on privacy-preserving technology and conservative investment approach suggests careful consideration of compliance requirements.
This strategic evolution could catalyze significant value creation by establishing first-mover advantages in blockchain-based genomic applications while maintaining traditional healthcare revenue streams.
The convergence of genomics, blockchain and AI represents a paradigm shift in healthcare delivery. The integration of CircleDNA with Humanity Protocol creates a unique value proposition: tamper-proof genetic identity verification that maintains privacy - a important requirement for healthcare applications.
The AI-driven cancer detection initiative through Insighta, backed by
- Enhanced pattern recognition in early-stage cancer detection
- Improved diagnostic accuracy through machine learning
- Faster processing of complex genomic data
The DeSci approach, combining decentralized research methodologies with traditional scientific rigor, could accelerate breakthrough discoveries while ensuring data integrity and reproducibility. The IM8 consumer health brand extends this innovation to daily wellness, creating a comprehensive healthcare ecosystem.
This integrated approach to healthcare innovation, combining secure identity management with advanced diagnostics, could significantly improve patient outcomes while maintaining data privacy - a critical consideration in the evolving healthcare landscape.
- CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US
$1.1b n after latest fundraise - Prenetics invests
$1.5M in Bitcoin, Solana and H tokens, supported by strong balance sheet - Prenetics advances Decentralized Science (DeSci) with AI-driven early cancer detection, backed by
$30M investment from Tencent
CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading genomics and consumer healthcare company, today announced a groundbreaking genomics-based partnership with Humanity Protocol, a decentralized identity verification company. This collaboration leverages Prenetics’ advanced genetic testing capabilities to underpin decentralized identity verification.
Prenetics is bringing its flagship CircleDNA service into Humanity Protocol’s infrastructure as an Identity Validator. This integration enables the issuance of blockchain-based Proof of Personhood credentials, leveraging DNA testing to deliver highly secure and sybil-resistant identity verification. With advanced zero-knowledge proof technology, these credentials ensure robust privacy protection while supporting decentralized applications across finance, healthcare, and governance.
In coordination, and at the root of this partnership, Prenetics has formed a Crypto Strategic Reserve aimed at fueling innovation at the intersection of blockchain, healthcare, and decentralized science (DeSci). As part of the dual initiative, Prenetics is committing initial investments of
Danny Yeung, CEO and Co-Founder of Prenetics, stated: “Our partnership with Humanity Protocol exemplifies our commitment to merging the precision of genomics with the transformative potential of blockchain technology, particularly with the increasing validity of direct generative based advancements in healthcare. Through our CircleDNA service, we will provide secure, privacy-focused identity solutions that not only benefits decentralized applications across finance, healthcare, and governance but also paves the way for a strategic framework that permits Prenetics to integrate and capitalize on digital assets.”
Yat Siu, Board Director of the Humanity Foundation and Executive Chairman of Animoca Brands, added: “Prenetics’ entry into the decentralized identity arena as an Identity Validator marks a significant milestone. Their deep expertise in genomics, now combined with an active role in the Web3 ecosystem, is exactly the kind of forward-thinking collaboration that will drive decentralized identity and secure digital interactions into the future.”
On Prenetics’ Crypto Strategic Reserve, Mr. Yeung said: “Our Crypto Strategic Reserve demonstrates Prenetics’ confidence in the unfolding potential of blockchain and digital assets. This initiative not only diversifies our balance sheet and asset portfolio but also reinforces our commitment to a decentralized ecosystem by leveraging cutting-edge technologies to drive cross-industry innovation in healthcare and beyond.”
Advancing DeSci, AI-Driven Early Cancer Detection and Consumer Healthcare
Building on its blockchain and identity initiatives, Prenetics has historically been at the forefront of innovation in decentralized science (DeSci) through its joint venture company, Insighta. Currently advancing through clinical trials, Insighta is dedicated to making AI-driven early cancer detection accessible to millions worldwide. With its
"Blockchain is creating unprecedented opportunities for innovation across industries," said Yeung. "By merging the rigor of genomics with digital innovation, we are forging a path toward a future where secure identity verification and groundbreaking healthcare solutions go hand in hand."
About Prenetics
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our
About Humanity Protocol
Humanity Protocol is an innovative decentralized identity solution that employs advanced technologies—ranging from palm recognition to DNA-based testing—to establish robust Proof of Humanity credentials. Its privacy-centric approach ensures sybil-resistant identity verification across various Web3 applications.
About Animoca Brands
Animoca Brands is a global leader in gamification, blockchain, and digital property rights. With a diverse portfolio of over 380 investments in Web3 projects, the company is dedicated to fostering innovation in the metaverse and driving the adoption of blockchain technologies across multiple industries.
Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com
FAQ
What is Prenetics' (PRE) new partnership with Humanity Protocol?
How much has Prenetics (PRE) invested in its Crypto Strategic Reserve?
What is Prenetics' (PRE) cash position as of December 31, 2024?
How much did Tencent invest in Prenetics' (PRE) Insighta venture?
What is Prenetics' (PRE) role in the Humanity Protocol ecosystem?
